<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01575288</url>
  </required_header>
  <id_info>
    <org_study_id>B6310</org_study_id>
    <nct_id>NCT01575288</nct_id>
  </id_info>
  <brief_title>Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults</brief_title>
  <official_title>Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Boulder</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Boulder</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study will assess the ability of a naturally occurring sugar to improve the
      function of arteries with age. Overall, the proposed research project has the long-term
      potential to influence clinical practice guidelines by establishing a novel, easy to deliver,
      cost-effective therapy for treating age-associated arterial dysfunction and reducing the risk
      of cardiovascular disease with age.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arterial Stiffness</measure>
    <time_frame>12 weeks</time_frame>
    <description>Arterial pulse wave velocity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>nitric-oxide mediated endothelium-dependent dilation</measure>
    <time_frame>12 weeks</time_frame>
    <description>flow-mediated dilation and forearm blood flow responses to acetylcholine in the presence and absence of N'-monomethyl-L-arginine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systemic oxidative stress and inflammation</measure>
    <time_frame>12 weeks</time_frame>
    <description>circulating markers of oxidative stress and inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell oxidative stress and inflammation</measure>
    <time_frame>12 weeks</time_frame>
    <description>inflammatory and oxidative stress markers in biopsied vascular and arterial endothelial cells</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>12 weeks</time_frame>
    <description>intravenous glucose tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell autophagic flux</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Vascular Aging</condition>
  <arm_group>
    <arm_group_label>Maltose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High-dose trehalose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>100g maltose 1/day</description>
    <arm_group_label>Maltose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High-dose trehalose</intervention_name>
    <description>100g 1/day</description>
    <arm_group_label>High-dose trehalose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women must be postmenopausal

          -  body mass index (BMI) &lt;40 kg/m2

          -  weight stable in the prior 3 months

          -  absence of clinical disease as determined by medical history, physical examination,
             blood and urine chemistries, ankle-brachial index, and a graded exercise stress test
             with monitoring of blood pressure and 12-lead ECG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rachelle E Kaplon, MS</last_name>
    <role>Study Director</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Douglas R Seals, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado, Boulder Clinical Translational Research Center</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.colorado.edu/intphys/research/cardiovascular.html</url>
    <description>Description of our Research and Laboratory</description>
  </link>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2012</study_first_submitted>
  <study_first_submitted_qc>April 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2012</study_first_posted>
  <last_update_submitted>December 9, 2015</last_update_submitted>
  <last_update_submitted_qc>December 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>arterial function</keyword>
  <keyword>cardiovascular</keyword>
  <keyword>aging</keyword>
  <keyword>endothelial function</keyword>
  <keyword>arterial stiffness</keyword>
  <keyword>vascular function</keyword>
  <keyword>Trehalose</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

